|
Volumn 29, Issue 7, 2011, Pages
|
Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DEXAMETHASONE;
HEMOGLOBIN;
MERCAPTOPURINE;
METHOTREXATE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
BACTEREMIA;
BODY TEMPERATURE;
DRUG INDUCED DISEASE;
FEBRILE NEUTROPENIA;
FEVER;
GENETIC RISK;
HEREDITY;
HIGH RISK POPULATION;
HUMAN;
LETTER;
LEUKOCYTE COUNT;
MORBIDITY;
MORTALITY;
OUTCOME VARIABLE;
PNEUMONIA;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
THROMBOCYTE COUNT;
ANTINEOPLASTIC AGENTS;
CHILD;
CHILD, PRESCHOOL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FEVER;
HUMANS;
MALE;
MODELS, STATISTICAL;
NEOPLASMS;
NEUTROPENIA;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RISK ASSESSMENT;
|
EID: 79952358568
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.32.7767 Document Type: Letter |
Times cited : (30)
|
References (5)
|